Time: 17:00-18:30 CET
REVIVE is an online space to connect and support the antimicrobial R&D community. REVIVE’s aims are to facilitate learning, connect people, and share knowledge. The REVIVE webinar series on antimicrobial drug discovery and R&D is brought to you by GARDP’s Antimicrobial Memory Recovery & Exploratory Programme.
REVIVE Webinar Series
Mining Chemical Libraries for New Antibacterials
Moderator: Benjamin Blasco, Discovery Senior Project Manager, GARDP
- Carl Balibar, Principal Scientist, Merck Research Laboratories
Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.
|Register here for this live webinar including interactive Q&A session on 21 May 2019, 17:00-18:30 (CEST).|
|If you have questions or comments, please let us know. Do so by posting them in our forum or submitting them via the ‘Talk to an expert’ feature. You can also send questions to: email@example.com|